139 related articles for article (PubMed ID: 12408500)
1. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature.
Korstanje A; den Hartog G; Biemond I; Lamers CB
Scand J Gastroenterol Suppl; 2002; (236):22-6. PubMed ID: 12408500
[TBL] [Abstract][Full Text] [Related]
2. [Potentialities of a serological method in diagnosis of atrophic gastritis].
Pimenov SI; Makarenko EV
Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
[TBL] [Abstract][Full Text] [Related]
3. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
4. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
5. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.
Broutet N; Plebani M; Sakarovitch C; Sipponen P; Mégraud F;
Br J Cancer; 2003 Apr; 88(8):1239-47. PubMed ID: 12698190
[TBL] [Abstract][Full Text] [Related]
6. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
7. GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.
Masci E; Pellicano R; Mangiavillano B; Luigiano C; Stelitano L; Morace C; Viale E; Freschi M; Locatelli M; Ieri R; Cavallaro A; Testoni S; Testoni PA
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):79-83. PubMed ID: 24632770
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
[TBL] [Abstract][Full Text] [Related]
9. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis.
Kim EH; Kang H; Park CH; Choi HS; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
Dig Liver Dis; 2015 Aug; 47(8):663-8. PubMed ID: 26077884
[TBL] [Abstract][Full Text] [Related]
10. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
[TBL] [Abstract][Full Text] [Related]
11. Histologic and serum risk markers for noncardia early gastric cancer.
Shiotani A; Iishi H; Uedo N; Kumamoto M; Nakae Y; Ishiguro S; Tatsuta M; Graham DY
Int J Cancer; 2005 Jun; 115(3):463-9. PubMed ID: 15688378
[TBL] [Abstract][Full Text] [Related]
12. [Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population].
Colarossi A; Inga R; Prochazka R; Reyes U; Bussalleu A; Barúa RL
Rev Gastroenterol Peru; 2011; 31(2):110-5. PubMed ID: 21836650
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
14. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
[TBL] [Abstract][Full Text] [Related]
15. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology.
Leja M; Kupcinskas L; Funka K; Sudraba A; Jonaitis L; Ivanauskas A; Janciauskas D; Kiudelis G; Chiu HM; Lin JT
Dig Dis Sci; 2009 Nov; 54(11):2377-84. PubMed ID: 19731026
[TBL] [Abstract][Full Text] [Related]
16. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study.
Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Mernova VP; Polyakova MB
Scand J Gastroenterol; 2005 Mar; 40(3):297-301. PubMed ID: 15932170
[TBL] [Abstract][Full Text] [Related]
17. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
18. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Bostick RM; Wu X; Yuan Y
Am J Gastroenterol; 2017 May; 112(5):704-715. PubMed ID: 28323271
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
Sipponen P; Ranta P; Helske T; Kääriäinen I; Mäki T; Linnala A; Suovaniemi O; Alanko A; Härkönen M
Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
[TBL] [Abstract][Full Text] [Related]
20. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.
Storskrubb T; Aro P; Ronkainen J; Sipponen P; Nyhlin H; Talley NJ; Engstrand L; Stolte M; Vieth M; Walker M; Agréus L
Scand J Gastroenterol; 2008; 43(12):1448-55. PubMed ID: 18663663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
